🇺🇸 FDA
Patent

US 9012618

Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures

granted A61KA61K2039/5156A61K2039/5254

Quick answer

US patent 9012618 (Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/5156, A61K2039/5254, A61K2039/5256, A61K2039/53